vs
Side-by-side financial comparison of Orange County Bancorp, Inc. (OBT) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.
Phathom Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($57.6M vs $33.0M, roughly 1.7× Orange County Bancorp, Inc.). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs 20.6%). Orange County Bancorp, Inc. produced more free cash flow last quarter ($41.3M vs $-167.0M).
Orange County Bancorp, Inc. is a Delaware-registered bank holding company operating mainly in New York, U.S. It offers a full range of retail and commercial banking services, including deposit accounts, loans and wealth management solutions, serving individual consumers, small and mid-sized corporate clients in its regional footprint.
Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.
OBT vs PHAT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $33.0M | $57.6M |
| Net Profit | $12.4M | — |
| Gross Margin | — | 86.7% |
| Operating Margin | 41.4% | — |
| Net Margin | 37.6% | — |
| Revenue YoY | 20.6% | 94.1% |
| Net Profit YoY | 73.5% | 71.6% |
| EPS (diluted) | $0.94 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $33.0M | $57.6M | ||
| Q3 25 | $33.7M | $49.5M | ||
| Q2 25 | $32.5M | $39.5M | ||
| Q1 25 | $28.0M | $28.5M | ||
| Q4 24 | $27.4M | $29.7M | ||
| Q3 24 | $27.1M | $16.4M | ||
| Q2 24 | $27.9M | $7.3M | ||
| Q1 24 | $25.3M | — |
| Q4 25 | $12.4M | — | ||
| Q3 25 | $10.0M | $-30.0M | ||
| Q2 25 | $10.5M | $-75.8M | ||
| Q1 25 | $8.7M | $-94.3M | ||
| Q4 24 | $7.2M | — | ||
| Q3 24 | $3.2M | $-85.6M | ||
| Q2 24 | $8.2M | $-91.4M | ||
| Q1 24 | $9.3M | — |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 87.5% | ||
| Q2 25 | — | 87.2% | ||
| Q1 25 | — | 86.9% | ||
| Q4 24 | — | 87.1% | ||
| Q3 24 | — | 85.6% | ||
| Q2 24 | — | 81.2% | ||
| Q1 24 | — | — |
| Q4 25 | 41.4% | — | ||
| Q3 25 | 38.6% | -30.8% | ||
| Q2 25 | 41.9% | -151.7% | ||
| Q1 25 | 40.3% | -276.5% | ||
| Q4 24 | 32.8% | — | ||
| Q3 24 | 14.8% | -433.0% | ||
| Q2 24 | 36.6% | -1055.4% | ||
| Q1 24 | 45.9% | — |
| Q4 25 | 37.6% | — | ||
| Q3 25 | 29.7% | -60.5% | ||
| Q2 25 | 32.2% | -191.9% | ||
| Q1 25 | 31.1% | -330.7% | ||
| Q4 24 | 26.2% | — | ||
| Q3 24 | 11.8% | -523.3% | ||
| Q2 24 | 29.4% | -1248.6% | ||
| Q1 24 | 36.7% | — |
| Q4 25 | $0.94 | — | ||
| Q3 25 | $0.75 | $-0.41 | ||
| Q2 25 | $0.87 | $-1.05 | ||
| Q1 25 | $0.77 | $-1.31 | ||
| Q4 24 | $0.64 | — | ||
| Q3 24 | $0.28 | $-1.32 | ||
| Q2 24 | $0.73 | $-1.56 | ||
| Q1 24 | $0.82 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $130.0M |
| Total DebtLower is stronger | — | $209.1M |
| Stockholders' EquityBook value | $284.4M | $-438.2M |
| Total Assets | $2.7B | $259.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $130.0M | ||
| Q3 25 | — | $135.2M | ||
| Q2 25 | — | $149.6M | ||
| Q1 25 | — | $212.3M | ||
| Q4 24 | — | $297.3M | ||
| Q3 24 | — | $334.7M | ||
| Q2 24 | — | $276.2M | ||
| Q1 24 | — | — |
| Q4 25 | — | $209.1M | ||
| Q3 25 | — | $207.1M | ||
| Q2 25 | — | $205.1M | ||
| Q1 25 | — | $203.2M | ||
| Q4 24 | — | $201.4M | ||
| Q3 24 | — | $175.7M | ||
| Q2 24 | — | $174.4M | ||
| Q1 24 | — | — |
| Q4 25 | $284.4M | $-438.2M | ||
| Q3 25 | $270.1M | $-422.5M | ||
| Q2 25 | $252.6M | $-405.8M | ||
| Q1 25 | $201.3M | $-338.4M | ||
| Q4 24 | $185.5M | $-253.6M | ||
| Q3 24 | $193.1M | $-187.1M | ||
| Q2 24 | $177.5M | $-233.8M | ||
| Q1 24 | $168.7M | — |
| Q4 25 | $2.7B | $259.1M | ||
| Q3 25 | $2.6B | $240.3M | ||
| Q2 25 | $2.6B | $250.2M | ||
| Q1 25 | $2.6B | $294.2M | ||
| Q4 24 | $2.5B | $378.3M | ||
| Q3 24 | $2.5B | $387.0M | ||
| Q2 24 | $2.5B | $319.4M | ||
| Q1 24 | $2.5B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $43.8M | $-166.8M |
| Free Cash FlowOCF − Capex | $41.3M | $-167.0M |
| FCF MarginFCF / Revenue | 125.1% | -290.0% |
| Capex IntensityCapex / Revenue | 7.6% | 0.4% |
| Cash ConversionOCF / Net Profit | 3.53× | — |
| TTM Free Cash FlowTrailing 4 quarters | $69.6M | $-328.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $43.8M | $-166.8M | ||
| Q3 25 | $30.2M | $-14.1M | ||
| Q2 25 | $-5.0M | $-62.7M | ||
| Q1 25 | $4.8M | $-84.9M | ||
| Q4 24 | $34.6M | $-266.8M | ||
| Q3 24 | $10.2M | $-63.6M | ||
| Q2 24 | $9.3M | $-70.7M | ||
| Q1 24 | $2.3M | — |
| Q4 25 | $41.3M | $-167.0M | ||
| Q3 25 | $29.6M | $-14.1M | ||
| Q2 25 | $-5.7M | $-62.8M | ||
| Q1 25 | $4.3M | $-84.9M | ||
| Q4 24 | $32.9M | $-266.9M | ||
| Q3 24 | $10.0M | $-63.6M | ||
| Q2 24 | $9.2M | $-70.8M | ||
| Q1 24 | $2.0M | — |
| Q4 25 | 125.1% | -290.0% | ||
| Q3 25 | 87.8% | -28.6% | ||
| Q2 25 | -17.5% | -159.0% | ||
| Q1 25 | 15.5% | -297.9% | ||
| Q4 24 | 120.0% | -899.8% | ||
| Q3 24 | 36.7% | -389.0% | ||
| Q2 24 | 32.8% | -966.2% | ||
| Q1 24 | 7.9% | — |
| Q4 25 | 7.6% | 0.4% | ||
| Q3 25 | 1.8% | 0.1% | ||
| Q2 25 | 2.3% | 0.2% | ||
| Q1 25 | 1.8% | 0.1% | ||
| Q4 24 | 6.3% | 0.5% | ||
| Q3 24 | 1.1% | 0.3% | ||
| Q2 24 | 0.4% | 0.6% | ||
| Q1 24 | 1.0% | — |
| Q4 25 | 3.53× | — | ||
| Q3 25 | 3.01× | — | ||
| Q2 25 | -0.47× | — | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 4.83× | — | ||
| Q3 24 | 3.19× | — | ||
| Q2 24 | 1.13× | — | ||
| Q1 24 | 0.24× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
